West Notes: Crisp, Sardinas, Dickerson, Padres, Paxton

Veteran Athletics outfielder Coco Crisp says that he believes the team is artificially holding down his playing time to prevent his option from vesting, Susan Slusser of the San Francisco Chronicle reports. Crisp says that he’s “extremely hurt” by the team’s “shady” handling of the situation. While GM David Forst and manager Bob Melvin have stated that Crisp is sitting against lefties to afford younger players more exposure, he sees more to it — particularly since he is not being used much off the bench. Crisp’s $13MM option vests at 130 games played; entering today’s action, he had appeared in 93 contests, meaning he’d need to take the field for most of the club’s remaining 43 games to reach the threshold. “I’m healthy, I’m playing hard and this has surprised me,” said Crisp, who noted that he has loved playing in Oakland. “This calls their integrity into question, it’s very sad.” The 36-year-old, who owns a .239/.307/.410 slash on the year, indicated that he may not be interested in playing after this season, adding: “The business side sure makes it hard to love the game, and I’ve loved the game since I was six years old.”

Here’s more from out west:

  • The Padres seemingly intend to give just-acquired infielder Luis Sardinas a good run late this year, as Dennis Lin of the San Diego Union-Tribune tweets. Though he hasn’t hit much at Triple-A or the majors thus far in 2016, Sardinas has a solid pedigree — as club GM A.J. Preller well knows having signed him as an amateur. “I don’t think we [acquired] him to relegate him to Triple-A the rest of the year,” said manager Andy Green.
  • One Padres player who has thrived upon receiving an opportunity is 26-year-old outfielder Alex Dickerson, who entered the day with a .280/.319/.528 slash and seven home runs over 135 plate appearances. Lin writes that there’s more concern over Dickerson’s glove than his bat, though Green also suggests he has been better than the defensive metrics might suggest. Still, the exciting element of Dickerson’s game is his work on offense. “The way he sees the ball, his plate discipline, he’s a guy that could easily have a 10 percent walk rate to go along with the way he hits, the power numbers he puts up,” said Green. “I’m very pleased with what he’s shown early in his major league career and have every expectation he’ll keep improving.”
  • It was reported recently that Major League Baseball is looking into the Padres‘ provision of medical information in a pair of recent trades. The initial review, at least, is expected to wrap up this week, Lin tweets. It remains largely unclear whether there’s any possibility of punitive measures being taken against the team, or whether the review is focused more on arriving at a standard approach to swapping health documents for all teams.
  • Mariners lefty James Paxton has been scratched from his next scheduled start, as Bob Dutton of the Tacoma News Tribune reports, and could be headed to the DL. Though Paxton wants to pitch, and the team no doubt wants to give him the ball, manager Scott Servais says that the prudent course is further rest. Forearm soreness is almost always scary, but in this case it resulted not from a throwing injury but a line drive. Regardless, Seattle will hope to get the southpaw back in action as soon as reasonably possible. The 27-year-old appears to be harnessing his talent at an opportune time for a Mariners team that is trying to make a run at a Wild Card, if not the AL West title. Over his 81 2/3 innings on the year, Paxton owns a 3.53 ERA with 8.0 K/9 against 2.0 BB/9, and he has been even better of late.

Jed Lowrie To Undergo Season-Ending Surgery

Athletics infielder Jed Lowrie will undergo surgery to remove a bunion and repair a ligament in his left foot, Susan Slusser of the San Francisco Chronicle was among those to report (links to Twitter). He is expected to miss the remainder of the season as a result of the procedure.

The veteran infielder has struggled with the problem for some time, and attempts to battle through it failed. He’ll have the work done now in hopes of having plenty of time to recover in advance of Spring Training next year.

Lowrie, 32, had seemed like a viable trade candidate prior to the foot problem and related struggles. He had been hitting at a fairly typical, roughly league-average clip before suffering through a rough month of July. As things stand, Lowrie owns a .263/.314/.322 batting line over 369 plate appearances on the year. Acquired over the winter to help anchor the Oakland infield, Lowrie has also posted below-average defensive ratings.

There’s no question that the foot malady has played a role, as reporters have documented how much of an impact it has had. Hopefully for both player and team, he’ll be able to return to full health in advance of the 2017 campaign. Lowrie is set to earn $6.5MM next year and can be controlled for an additional season with a $6MM club option, which comes with a $1MM buyout.

Shin-Soo Choo Suffers Fractured Forearm

Rangers outfielder Shin-Soo Choo is hitting the DL with a fractured left forearm, according to an announcement from VP of communications John Blake. The tough-luck injury occurred on a hit-by-pitch.

Given that it’s mid-August, it’s certainly possible that Choo’s latest injury could keep him out for the rest of the season. After all, Jon Jay is still on the DL after breaking his forearm nearly two months ago. And Rangers catcher Robinson Chirinos missed two months with his own, similar injury.

That sort of timetable makes a post-season return possible, though that may be a tall ask if Choo doesn’t have a chance to rehab in live game action. And it isn’t yet clear whether Choo will require a full two months; we’ll need to wait to learn of his particular prognosis.

Regardless, it’s a big blow to Texas and to Choo. It seems that Ryan Rua will take his spot on the active roster, and the club also has slugger Joey Gallo available. Those two will be useful replacements, as will Delino DeShields Jr., and Drew Stubbs, and the club can mix and match at its leisure once rosters expand in September.

But Choo remains a strong on-base threat at 34 years of age, and is especially excellent against right-handed pitching (despite carrying reverse platoon splits in his limited action this year), making him a difficult player to replace. It just hasn’t been meant to be this year, as he has now hit the DL on four separate occasions for a variety of ailments. Texas has already needed to find replacements for Josh Hamilton (Ian Desmond) and Prince Fielder (Carlos Beltran) earlier in the year.

If the Rangers do take to the market once more, they’ll have a few options, as MLBTR’s top twenty current trade candidates list shows. Melky Cabrera would represent a rather similar player, though the Rangers may not love the idea of taking over his future commitments. Brett Gardner and Nick Markakis are other potential left-handed-hitting options. Carlos Gomez can be had, though he’s an uncertain commodity and hits from the right side.

Looking past the present campaign, Choo remains a somewhat frustrating player for the Rangers. He carries a useful .259/.361/.422 slash over 1,377 plate appearances since signing before the 2014 season. But that’s not quite what the team hoped to receive out of the first three of seven years in his huge contract. Choo is still owed $82MM over the remainder of that pact.

Garrett Richards Resumes Throwing

It’s not often that news relating to an ulnar collateral ligament is promising, but it certainly seems as if there’s now real hope that Angels righty Garrett Richards can avoid Tommy John surgery. The staff ace’s latest trip to the doctor revealed sufficient healing that he can begin throwing, Mike DiGiovanna of the Los Angeles Times was among those to report (Twitter links).

Richards did indeed pick up the ball today, making 25 tosses from 45 feet. He says that it felt like the first day of spring camp — which seemingly represents yet another sign of hope. Presumably, his throwing program will be heavily dependent upon how he feels and will proceed at a measured pace.

While there are still many hurdles remaining for the 28-year-old, it is remarkable that he has made it this far in his endeavor to avoid going under the knife. At the time that Richards’s UCL tear was first reported, in early May, the assumption was that he was headed for a procedure. While some minor tears don’t require surgery, his was initially seen as a clear case.

It was surprising, then, when the news emerged that Richards — as well as lefty Andrew Heaney — would attempt a platelet-rich plasma and stem cell treatment. By not immediately undertaking a TJ procedure, Richards sacrificed any chance of returning for the end of next season if he did ultimately have it performed. But he also gained the possibility, however slight it seemed, of pitching a full 2017 season.

Heaney chose the same path, but ultimately did not show sufficient improvement and ended up with a replacement UCL. But Richards has continued to respond to the treatment, saying recently that his arm feels great. It still remained to be seen whether and when his doctors would clear him to throw, but he finally was allowed to do so with promising results.

While it is certainly fantastic news that Richards has reached this point, the true tests are yet to come. The expectation is that he’ll try to build up towards competitive action this fall — perhaps including a stint in the Arizona Fall League. If Richards can stay on that track and return to full mound work in live game action, then there would be sufficient confidence in the ligament that he’d look to prepare for Spring Training in 2017.

The stakes remain high for both player and team. Indeed, if anything, they are increasing. If he were to swap out UCLs within the next month or two, he’d likely be ready for the start of the 2018 campaign. If he ultimately needs it at a later date — say, early next year — then much of that season could too be in jeopardy.

In spite of the downside, it’s hard not to see the reasoning behind the decisionmaking. For Richards, a return to health now would mean a chance not only to return to action in short order, but also to earn a slight bump on his $6.425MM arbitration salary rather than potentially hitting the open market following a non-tender.

For the Halos, it’s an opportunity to reap the rewards of Richards’s highly valuable pre-free agent seasons. Even if he had gone through with the surgery in May, it would have been difficult to tender him a contract for each of the next two years just in hopes that he’d be ready to go for the start of the 2018 season — his final campaign before qualifying for free agency.

After all, a healthy Richards represents a powerful, top-of-the-rotation piece for a Los Angeles team that badly needs one. Working off of a mid-to-upper-nineties fastball, Richards has nudged his swinging strike rate upward in recent years while generally limiting the damage on balls put in play against him with a solid groundball rate. Since the start of his breakout 2014 season, Richards has worked to a 3.11 ERA with 8.2 K/9 and 3.1 BB/9 over 410 2/3 innings.

This story is notable even beyond what it means for Richards and the Angels. It scarcely bears mentioning that the fragility of the ulnar collateral ligament has been a major issue in baseball in recent years. Numerous high-profile hurlers have succumbed to the surgery, and while its success rate remains quite high, it’s no sure thing — and also represents a major risk factor for another such procedure. If Richards’s seemingly novel treatment works out, it could provide an alternative in appropriate cases.

Diamondbacks Designate Adam Loewen

The Diamondbacks have designated lefty Adam Loewen for assignment, per a club announcement. Arizona has also activated catcher Welington Castillo and recalled southpaw Edwin Escobar.

Loewen, 32, has seen big league action as a starter, an outfielder, and — most recently — a reliever. He struggled through six innings for the D-Backs during a brief stint, allowing ten earned runs while issuing six walks and recording only three strikeouts.

The multi-functional ballplayer had been much more effective at Triple-A this year, where he recorded a 3.52 ERA in 38 1/3 innings and racked up 9.6 K/9. On the other hand, he also handed out a troubling 28 free passes in that span, continuing a longstanding battle with control.

Loewen was taken with the fourth overall pick in the 2002 draft by the Orioles. He showed promise as a starter in the Baltimore farm system, but was never able to stick at the major league level. Loewen switched to the position-player side in 2009, and again moved through the minor league ranks — this time with the Blue Jays. Despite posting a .306/.377/.508 slash in 585 Triple-A plate appearances in 2011, though, he earned only a brief big league cameo as a hitter that year and eventually moved back to the rubber.

Twins Designate Andrew Albers

The Twins have designated lefty Andrew Albers for assignment, Mike Berardino of the St. Paul Pioneer-Press was among those to tweet. His replacement has yet to be determined, but Minnesota is in need of fresh arms, necessitating the move.

Albers, 30, had only just returned to the majors and only received one appearance. It was a useful one, though, as he contributed six bullpen-saving innings in relief, allowing 11 hits and three earned runs but also striking out five batters against one walk.

The opportunities have been scarce for Albers, who only has 68 2/3 MLB frames on his ledger, with most of those coming in a 2013 run with the Twins. He opened the current season in independent ball, but has mostly pitched at Triple-A Rochester as a starter. Over his 112 2/3 frames there, Albers owns a 3.51 ERA with 5.8 K/9 against 2.2 BB/9.

Injury Notes: Harper, De La Rosa, Rasmus, Bour, Gray, Cishek, Zych

A slumping Bryce Harper was out of the lineup again tonight for the Nationals owing to a seemingly minor neck issue, but the precise nature of his injury has been the subject of some debate. Chelsea Janes of the Washington Post breaks down all the back-and-forth on the topic. In essence, Nats GM Mike Rizzo strongly denied a report from SI.com’s Tom Verducci indicating that Harper may have been playing through a shoulder injury for some time. Rizzo insists that Harper simply has a stiff neck that has not yet required a DL placement.

Here’s more on some injury situations around the game:

  • Diamondbacks righty Rubby De La Rosa has suffered a setback in his efforts to come back from a forearm injury, Steve Gilbert of MLB.com tweets. He’s headed for an MRI to see where things stand. It seems as if there’s little reason to expect the 27-year-old to return to the majors this season. That’s a tough blow for the D-Backs, who surely would like to get a longer look at a pitcher who showed a fair bit of promise this year. Over 47 2/3 innings earlier in the season, De La Rosa worked to a 4.15 ERA with 9.3 K/9 against 2.8 BB/9.
  • The Astros will be without Colby Rasmus for a month or more after he underwent surgery to remove a cyst from his ear, Jake Kaplan of the Houston Chronicle tweets. Rasmus has been struggling for some time, and it’s fair to wonder whether the issue may have played a significant role. He’ll need to return in good form to provide a boost to the ‘Stros — and to bolster his fading free agent position.
  • Marlins first baseman Justin Bour isn’t progressing in his attempt to return from an ankle injury, as Barry Jackson of the Miami Herald reports on Twitter. In fact, manager Don Mattingly says that Bour “went backwards” of late, with the team’s expectation now being that he won’t return until at least early September. That certainly seems to open some room for Miami to look into adding a bat to chip in down the stretch.
  • Athletics righty Sonny Gray only just began forearm exercises today, John Hickey of the Bay Area News Group reports. He won’t begin throwing again unless and until the inflammation subsides. At this point, it seems far from certain whether he’ll make it back to a major league hill this season.
  • The Mariners may soon send reliever Steve Cishek out on a rehab assignment, Bob Dutton of the Tacoma News Tribune reports. It appears that his hip labrum issue is indeed as minor as the team had suggested. Meanwhile, fellow pen righty Tony Zych is also finally making some progress and will begin a rehab assignment on Friday. Adding those two arms down the stretch would provide a significant boost to Seattle’s late-inning mix.

Tigers Place Jose Iglesias On 15-Day DL

The Tigers have placed shortstop Jose Iglesias on the 15-day DL with a left hamstring strain, MLB.com’s Jason Beck reports on Twitter. His active roster spot will be taken over by righty Warwick Saupold.

[Related: Updated Tigers Depth Chart]

Detroit will utilize utilityman Andrew Romine at shortstop for the time being. But with third baseman Nick Castellanos also sidelined, there’s increasing pressure on the organization to find an outside addition on the left side of the infield. That’s all before considering the needs that have arisen from injuries to outfielder Cameron Maybin as well as pitchers Jordan Zimmerman and Mike Pelfrey.

Iglesias, 26, has not produced at the league-average rate that he did last year. Over his 399 plate appearances in 2016, he’s slashing just .249/.297/.328. Still, he has managed to rate as a middle-tier starting option at the shortstop position (by measure of fWAR) owing to his top-line glovework.

It’s not yet clear whether Detroit will act to fill the void with a trade — particularly given that there’s no timeline as yet for Iglesias to return. Hamstring issues, it bears noting, are notorious for lingering. While Castellanos is expected back by early to mid-September, he’ll be working back from a fractured hand that could pose its own uncertainties. And his replacement, the veteran Casey McGehee, has struggled of late in the majors, though he was hitting well at Triple-A.

Of course, finding a match is more complicated in August. With the trade deadline having already passed, the Tigers would be left looking at waiver claims or players who have already cleared. Still, with Detroit sitting a half game out of the Wild Card and four back in the AL Central, wins are at a premium. Only one shortstop, Zack Cozart, cracked MLBTR’s latest listing of the top trade candidates, though he’d be a tough target given his appealing contract status and solid play (which not only raises the acquisition cost, but makes him a likely player to be claimed by teams with higher waiver priority). There are several third basemen who could potentially be had, though none would help account for the absence of Iglesias.

The Tigers do have some options kicking around at Triple-A, of course, and it appears that the team is preparing to use them. John Wagner of the Toledo Blade tweets that both shortstop Dixon Machado and outfielder Alex Presley aren’t in tonight’s lineup for the club’s top affiliate, suggesting that either or both could be on the way to the majors in short order. Machado, 24, struggled in limited action in the majors last year, and carries a .266/.356/.354 batting line in his 507 Triple-A plate appearances this season.

Angels Claim Cody Ege

The Angels have claimed southpaw Cody Ege off waivers from the Marlins, per an announcement from Los Angeles. Right-hander Nick Tropeano was moved to the 60-day DL to create a 40-man opening.

Ege, 25, will head to Triple-A Salt Lake City to begin his tenure in the Los Angeles organization. He has spent most of the year at that level with Miami, compiling a 4.50 ERA over 44 frames with 7.2 K/9 and 5.5 BB/9.

That obviously isn’t a terribly promising pitching line, though Ege did earn a brief MLB promotion. He was also much better in the upper minors last year — good enough, in fact, to be a part of an under-the-radar deadline trade that has turned out to be more important than it initially seemed.

Ege was dealt along with Tomas Telis in the deal that sent Sam Dyson to the Rangers. That swap has certainly had an impact on both organizations, as Texas has utilized Dyson as its closer while the Fish have been forced to hunt for extra arms at the back of their pen.

Zack Wheeler To Visit Dr. Andrews After Elbow Discomfort

Mets righty Zack Wheeler is set for a visit to orthopedist Dr. James Andrews after experiencing discomfort in his surgically-repaired right elbow, Mike Puma of the New York Post was among those to tweet. It seems that the flare-up occurred after his most recent rehab outing.

Though it’s still far from clear whether Wheeler has a new injury with which to contend, the news makes it tough to imagine that he’ll return to New York this season. The prized 26-year-old had seemed primed to make a late-season return from Tommy John surgery, potentially giving the Mets a boost down the stretch.

At this point, the greater concern lies in the long run. Wheeler last pitched in the majors in 2014, when he wrapped up a stellar campaign for the Mets. He had been brought back slowly from his UCL replacement procedure, but attempts to ramp things up toward a major league return have not gone according to plan. Now, a dreaded trip to the famed Dr. Andrews may help to ascertain whether there’s a new problem to contend with.

The expectation has long been that Wheeler would constitute a major part of a loaded Mets pitching staff full of frontline starters. But while Noah Syndergaard and Jacob deGrom have continued to thrive, though the former has pitched through a bone spur, but some cracks have formed elsewhere. Though Steven Matz has been productive in his first full MLB campaign, he has dealt with some inconsistency while battling his own elbow bone spur. And Matt Harvey has undergone a shocking downfall, struggling badly before undergoing season-ending surgery.

Wheeler certainly deserves mention in that company. Over his first 285 1/3 innings at the big league level, from 2013-14, Wheeler owns a 3.50 ERA with 8.5 K/9 against 3.8 BB/9. Returning to that form may once have seemed a foregone conclusion, given the prevalence of Tommy John surgery, but the fact is that the surgery isn’t always successful. Indeed, as MLBTR contributor Bradley Woodrum has explained, a prior TJ procedure “strongly predicts a second surgery.”